Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19

Wei Luo(Shanxi Medical University), Dawei Ye(Huazhong University of Science and Technology), Qian Chen(Second Affiliated Hospital of Xi'an Jiaotong University), Tao Wang(Union Hospital), Yixin Li(Shanxi Medical University), Lijun Jiang(Tongji Hospital)
Trends in Pharmacological Sciences
June 17, 2020
10.1016/j.tips.2020.06.007
Cited by 304

Related Papers

Persistent sulfate formation from London Fog to Chinese haze
|Proceedings of the National Academy of Sciences|2016|1.6k
Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy
|Nature Communications|2016|1.6k
Identifying airborne transmission as the dominant route for the spread of COVID-19
|Proceedings of the National Academy of Sciences|2020|1.3k
Programmable probiotics modulate inflammation and gut microbiota for inflammatory bowel disease treatment after effective oral delivery
|Nature Communications|2022|632
New Particle Formation in the Atmosphere: From Molecular Clusters to Global Climate
|Journal of Geophysical Research Atmospheres|2019|431